نتائج البحث - "Nimer, S."

1

Academic Journal

Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective.

المؤلفون: Nimer S Alkhatib, Abdulaali R Almutairi, Majid Almadi, Shiraz Halloush, Yazed Sulaiman H Al-Ruthia, Omar Rashdan, Samah Al-Shatnawi, Nahla A Azzam, Mahmoud H Mosli, Amal M Badawoud, Majed S Al Yami, Abdulaziz Alhossan, Ibtisam AlHarbi

المصدر: PLoS ONE, Vol 19, Iss 11, p e0312603 (2024)

مصطلحات موضوعية: Medicine, Science

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1932-6203

URL الوصول: https://doaj.org/article/5501913ce9d344d686fd7db90836d8cc

View record in DOAJ

Full Text Finder

2

Academic Journal

The economic impact of tobacco smoking and secondhand smoke exposure in Jordan: estimating the direct and indirect costs

المؤلفون: Alkhatib, Nimer S., Massad, Eman, Rashdan, Omar, Max, Wendy, Halloush, Shiraz, Abumansour, Hamza, Alkhatib, Ala’a, Karasneh, Reema A., Al-Shatnawi, Samah, Qirim, Tariq, Hawari, Feras, Alkhatib, Said

المساهمون: Al-Zaytoonah University of Jordan

المصدر: Journal of Medical Economics ; volume 27, issue 1, page 880-886 ; ISSN 1369-6998 1941-837X

الاتاحة: http://dx.doi.org/10.1080/13696998.2024.2373002
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2024.2373002

View record in BASE

3

Academic Journal

Economic analysis of glucagon like peptide-1 receptor agonists from the Saudi Arabia payer perspective

المؤلفون: Nimer S. Alkhatib, Abdulaali R. Almutairi, Omar S. Alkhezi, Osama M. Alfayez, Majed S. Al Yami, Omar A. Almohammed

المصدر: Saudi Pharmaceutical Journal, Vol 30, Iss 4, Pp 433-439 (2022)

مصطلحات موضوعية: GLP1RAs, Budget impact analysis, Economic evaluation, Diabetes mellitus, Saudi Arabia, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1319016422000251; https://doaj.org/toc/1319-0164

URL الوصول: https://doaj.org/article/0cf5d1afa6db429a8c5b461c067c9582

View record in DOAJ

Full Text Finder

4

Academic Journal

Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective

المؤلفون: Halloush, Shiraz, Alkhatib, Nimer S., Almutairi, Abdulaali R., Calamia, Mathias, Halawah, Hala, Obeng-Kusi, Mavis, Hoyle, Martin, Rashdan, Omar, Koeller, Jim, Abraham, Ivo

المصدر: Annals of Pharmacotherapy ; volume 57, issue 9, page 1016-1024 ; ISSN 1060-0280 1542-6270

الاتاحة: https://doi.org/10.1177/10600280221146878
http://journals.sagepub.com/doi/pdf/10.1177/10600280221146878
http://journals.sagepub.com/doi/full-xml/10.1177/10600280221146878

View record in BASE

5

Academic Journal

Cost-efficiency analysis and expanded treatment access modeling of conversion to rituximab biosimilars from reference rituximab in Jordan

المؤلفون: Halawah, Hala H., Alkhatib, Nimer S., Almutairi, Abdulaali R., Saleh, Mohammad, Halloush, Shiraz S., Rashdan, Omar, Masadh, Lama, Abusara, Osama H., Abraham, Ivo

المصدر: Journal of Medical Economics ; volume 26, issue 1, page 835-842 ; ISSN 1369-6998 1941-837X

الاتاحة: http://dx.doi.org/10.1080/13696998.2023.2226007
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2023.2226007

View record in BASE

6

Academic Journal

Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective.

المؤلفون: Alkhatib, Nimer S., Almutairi, Abdulaali R., Almadi, Majid, Halloush, Shiraz, Al-Ruthia, Yazed Sulaiman H., Rashdan, Omar, Al-Shatnawi, Samah, Azzam, Nahla A., Mosli, Mahmoud H., Badawoud, Amal M., Al Yami, Majed S., Alhossan, Abdulaziz, AlHarbi, Ibtisam

المصدر: PLoS ONE; 11/12/2024, Vol. 19 Issue 11, p1-14, 14p

مصطلحات موضوعية: CROHN'S disease, INFLAMMATORY bowel diseases, ULCERATIVE colitis, BUDGET, DRUG prices, TIME perspective

Full Text Finder

7

Academic Journal

Cost-effectiveness of palonosetron and dexamethasone-based triple and quadruple regimens in preventing highly emetogenic chemotherapy-induced nausea and vomiting

المؤلفون: Shiraz Halloush (6810914), Abdullah A. Alhifany (8675259), Nimer S. Alkhatib (9304126), Abdel Qader Al Bawab (12039380), Batool AL-Qawasmeh (11988591), Esra’a Al Shawakri (12039383), Jim Koeller (3552269)

مصطلحات موضوعية: Medicine, Physiology, Pharmacology, Ecology, Sociology, Cancer, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, Cost-effectiveness, antiemetics, chemotherapy-induced nausea, olanzapine, neurokinin-1 receptor antagonist

Relation: https://figshare.com/articles/journal_contribution/Cost-effectiveness_of_palonosetron_and_dexamethasone-based_triple_and_quadruple_regimens_in_preventing_highly_emetogenic_chemotherapy-induced_nausea_and_vomiting/18865716

الاتاحة: https://doi.org/10.6084/m9.figshare.18865716.v2

View record in BASE

8

Academic Journal

The six Delta platform for outcome-based contracting for pharmaceuticals

المؤلفون: Alkhatib, Nimer S., Abraham, Ivo

المصدر: Journal of Medical Economics ; volume 23, issue 11, page 1209-1214 ; ISSN 1369-6998 1941-837X

الاتاحة: https://doi.org/10.1080/13696998.2020.1824161
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1824161

View record in BASE

9

Academic Journal

Pricing methods in outcome-based contracting: δ1: cost effectiveness analysis and cost-utility analysis-based pricing

المؤلفون: Alkhatib, Nimer S., Ramos, Kenneth, Erstad, Brian, Slack, Marion, McBride, Ali, Bhattacharjee, Sandipan, Abraham, Ivo

المصدر: Journal of Medical Economics ; volume 23, issue 11, page 1215-1222 ; ISSN 1369-6998 1941-837X

الاتاحة: http://dx.doi.org/10.1080/13696998.2020.1815025
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1815025

View record in BASE

10

Academic Journal

Pricing methods in outcome-based contracting: δ4: safety-based pricing

المؤلفون: Alkhatib, Nimer S., Bhattacharjee, Sandipan, McBride, Ali, Ramos, Kenneth, Slack, Marion, Erstad, Brian, Abraham, Ivo

المصدر: Journal of Medical Economics ; volume 23, issue 11, page 1237-1245 ; ISSN 1369-6998 1941-837X

الاتاحة: http://dx.doi.org/10.1080/13696998.2020.1815028
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1815028

View record in BASE

11

Academic Journal

Pricing methods in outcome-based contracting: δ2: willingness-to-pay-based pricing

المؤلفون: Alkhatib, Nimer S., Ramos, Kenneth, Erstad, Brian, Slack, Marion, McBride, Ali, Bhattacharjee, Sandipan, Abraham, Ivo

المصدر: Journal of Medical Economics ; volume 23, issue 11, page 1223-1229 ; ISSN 1369-6998 1941-837X

الاتاحة: http://dx.doi.org/10.1080/13696998.2020.1815026
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1815026

View record in BASE

12

Academic Journal

Pricing methods in outcome-based contracting: integration analysis of the six dimensions (6 δs)

المؤلفون: Alkhatib, Nimer S., McBride, Ali, Slack, Marion, Bhattacharjee, Sandipan, Erstad, Brian, Ramos, Kenneth, Abraham, Ivo

المصدر: Journal of Medical Economics ; volume 23, issue 11, page 1266-1272 ; ISSN 1369-6998 1941-837X

الاتاحة: http://dx.doi.org/10.1080/13696998.2020.1815031
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1815031

View record in BASE

13

Academic Journal

Pricing methods in outcome-based contracting: δ6: adherence-based pricing

المؤلفون: Alkhatib, Nimer S., Slack, Marion, Bhattacharjee, Sandipan, Erstad, Brian, Ramos, Kenneth, McBride, Ali, Abraham, Ivo

المصدر: Journal of Medical Economics ; volume 23, issue 11, page 1256-1265 ; ISSN 1369-6998 1941-837X

الاتاحة: http://dx.doi.org/10.1080/13696998.2020.1815030
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1815030

View record in BASE

14

Academic Journal

Pricing methods in outcome-based contracting: δ5: risk of efficacy failure-based pricing

المؤلفون: Alkhatib, Nimer S., McBride, Ali, Bhattacharjee, Sandipan, Ramos, Kenneth, Erstad, Brian, Slack, Marion, Billheimer, Dean, Abraham, Ivo

المصدر: Journal of Medical Economics ; volume 23, issue 11, page 1246-1255 ; ISSN 1369-6998 1941-837X

الاتاحة: http://dx.doi.org/10.1080/13696998.2020.1815029
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1815029

View record in BASE

15

Academic Journal

Pricing methods in outcome-based contracting: δ3: reference-based pricing

المؤلفون: Alkhatib, Nimer S., Erstad, Brian, Ramos, Kenneth, McBride, Ali, Bhattacharjee, Sandipan, Slack, Marion, Abraham, Ivo

المصدر: Journal of Medical Economics ; volume 23, issue 11, page 1230-1236 ; ISSN 1369-6998 1941-837X

الاتاحة: http://dx.doi.org/10.1080/13696998.2020.1815027
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1815027

View record in BASE

16

Academic Journal

Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma

المؤلفون: Almutairi, Abdulaali R., Alkhatib, Nimer S., Oh, Mok, Curiel-Lewandrowski, Clara, Babiker, Hani M., Cranmer, Lee D., McBride, Ali, Abraham, Ivo

المصدر: JAMA Dermatology ; volume 155, issue 1, page 22 ; ISSN 2168-6068

الاتاحة: http://dx.doi.org/10.1001/jamadermatol.2018.3958
https://jamanetwork.com/journals/jamadermatology/fullarticle/2715092

View record in BASE

17

Academic Journal

The status and preparation for the next decade of biosimilars in the Middle Eastern and North African region

المؤلفون: Alkhatib, Nimer S, Halloush, Shiraz, Abraham, Ivo

المصدر: Expert Opinion on Biological Therapy ; volume 23, issue 8, page 671-677 ; ISSN 1471-2598 1744-7682

الاتاحة: http://dx.doi.org/10.1080/14712598.2023.2241346
https://www.tandfonline.com/doi/pdf/10.1080/14712598.2023.2241346

View record in BASE

18

Academic Journal

THE NLRC4 INFLAMMASOME DRIVES MYELODYSPLASTIC SYNDROME BY LINKING EPIGENETIC REPROGRAMMING AND INNATE IMMUNE SIGNALING

المؤلفون: Chen, C., Man, N., Tamiro, F., Hossack, K., Martinez, C., Bilbao, D., Poveda, J., Martin, G. Mas, Duffort, S., Liu, F., Itonaga, H., Chapman, J., Nimer, S.

المصدر: Leukemia Research ; volume 128, page 107114 ; ISSN 0145-2126

الاتاحة: http://dx.doi.org/10.1016/j.leukres.2023.107114
https://api.elsevier.com/content/article/PII:S0145212623001108?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0145212623001108?httpAccept=text/plain

View record in BASE

19

sj-docx-1-aop-10.1177_10600280221146878 – Supplemental material for Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective

المؤلفون: Halloush, Shiraz, Alkhatib, Nimer S., Almutairi, Abdulaali R., Calamia, Mathias, Halawah, Hala, Obeng-Kusi, Mavis, Hoyle, Martin, Rashdan, Omar, Koeller, Jim, Abraham, Ivo

مصطلحات موضوعية: FOS: Clinical medicine, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8fe1575dec2a28c9d0ea193e91f1721

View record in OpenAIRE

20

Cost-efficiency analysis and expanded treatment access modeling of conversion to rituximab biosimilars from reference rituximab in Jordan

المؤلفون: Halawah, Hala H, Alkhatib, Nimer S, Almutairi, Abdulaali R, Saleh, Mohammad, Halloush, Shiraz S, Rashdan, Omar, Masadh, Lama, Abusara, Osama H, Abraham, Ivo

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3780a1dd2076cb8e6fe37ed08b19b523

View record in OpenAIRE

تنقيح النتائج